BHVN
BiohavenยทNYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BHVN Profile
Biohaven Ltd.
A commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to debilitating neurological and neuropsychiatric diseases
215 Church Street, New Haven, Connecticut 06510
--
Biohaven Ltd., is a British Virgin Islands commercial limited liability company incorporated in the British Virgin Islands on May 2, 2022. The company is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience and oncology. The company is advancing a portfolio of innovative therapies, leveraging proven drug development experience and multiple proprietary drug development platforms.
